Hybrid Sensor To Help Diagnose Cancer Developed

Jun 18, 2022

A team of researchers at Moscow has developed a nanophotonic-microfluidic sensor whose potential applications include cancer detection, monitoring, and treatment response assessment.

The study indicates that the device can identify gases and liquids dissolved at low concentrations with a high degree of accuracy. A ‘lab-on-a-chip’ is a miniature sensor device capable of performing complex biochemical analysis which is considered one of the most promising approaches to early cancer detection.

Russian researchers have developed a new hybrid nanophotonic-microfluidic sensor for highly sensitive analysis of liquids and gases at very low concentrations in solutions. This makes it possible to obtain results even from very small samples, something that can be critical when an on-site analysis is not feasible and specimens must be transported elsewhere for examination.

Source : IANS